492 related articles for article (PubMed ID: 15388993)
41. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
Martens MC; Emmert S; Boeckmann L
Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
[TBL] [Abstract][Full Text] [Related]
42. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients.
Otto AI; Riou L; Marionnet C; Mori T; Sarasin A; Magnaldo T
Cancer Res; 1999 Mar; 59(6):1212-8. PubMed ID: 10096550
[TBL] [Abstract][Full Text] [Related]
43. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
Moriwaki S; Kraemer KH
Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
[TBL] [Abstract][Full Text] [Related]
44. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes.
Dumaz N; Duthu A; Ehrhart JC; Drougard C; Appella E; Anderson CW; May P; Sarasin A; Daya-Grosjean L
Mol Carcinog; 1997 Dec; 20(4):340-7. PubMed ID: 9433478
[TBL] [Abstract][Full Text] [Related]
45. The discovery that xeroderma pigmentosum (XP) results from defective nucleotide excision repair.
Friedberg EC
DNA Repair (Amst); 2004 Feb; 3(2):183, 195. PubMed ID: 14706352
[TBL] [Abstract][Full Text] [Related]
46. Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.
Zeng L; Sarasin A; Mezzina M
Cell Biol Toxicol; 1998 Mar; 14(2):105-10. PubMed ID: 9553721
[TBL] [Abstract][Full Text] [Related]
47. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
Brooks PJ
Neuroscience; 2007 Apr; 145(4):1407-17. PubMed ID: 17184928
[TBL] [Abstract][Full Text] [Related]
48. Xeroderma Pigmentosum - Facts and Perspectives.
Lehmann J; Seebode C; Martens MC; Emmert S
Anticancer Res; 2018 Feb; 38(2):1159-1164. PubMed ID: 29374753
[TBL] [Abstract][Full Text] [Related]
49. Replication of damaged DNA: molecular defect in xeroderma pigmentosum variant cells.
Cordonnier AM; Fuchs RP
Mutat Res; 1999 Oct; 435(2):111-9. PubMed ID: 10556591
[TBL] [Abstract][Full Text] [Related]
50. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes.
Carreau M; Eveno E; Quilliet X; Chevalier-Lagente O; Benoit A; Tanganelli B; Stefanini M; Vermeulen W; Hoeijmakers JH; Sarasin A
Carcinogenesis; 1995 May; 16(5):1003-9. PubMed ID: 7767957
[TBL] [Abstract][Full Text] [Related]
51. Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers.
Nasrallah A; Fayyad N; Kobaisi F; Badran B; Fayyad-Kazan H; Fayyad-Kazan M; Sève M; Rachidi W
Oxid Med Cell Longev; 2021; 2021():6689403. PubMed ID: 34630850
[TBL] [Abstract][Full Text] [Related]
52. [Xeroderma pigmentosum (XP) : A genetic disease sheds light on UV-induced skin cancer].
Emmert B; Hallier E; Schön MP; Emmert S
Hautarzt; 2011 Feb; 62(2):91-7. PubMed ID: 21243329
[TBL] [Abstract][Full Text] [Related]
53. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
54. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Rass K; Reichrath J
Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
[TBL] [Abstract][Full Text] [Related]
55. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.
van Steeg H; Kraemer KH
Mol Med Today; 1999 Feb; 5(2):86-94. PubMed ID: 10200950
[TBL] [Abstract][Full Text] [Related]
56. Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches.
Lehmann J; Schubert S; Emmert S
J Dtsch Dermatol Ges; 2014 Oct; 12(10):867-72. PubMed ID: 25262888
[TBL] [Abstract][Full Text] [Related]
57. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity.
Masutani C; Araki M; Yamada A; Kusumoto R; Nogimori T; Maekawa T; Iwai S; Hanaoka F
EMBO J; 1999 Jun; 18(12):3491-501. PubMed ID: 10369688
[TBL] [Abstract][Full Text] [Related]
58. Relationship of the xeroderma pigmentosum group E DNA repair defect to the chromatin and DNA binding proteins UV-DDB and replication protein A.
Rapić Otrin V; Kuraoka I; Nardo T; McLenigan M; Eker AP; Stefanini M; Levine AS; Wood RD
Mol Cell Biol; 1998 Jun; 18(6):3182-90. PubMed ID: 9584159
[TBL] [Abstract][Full Text] [Related]
59. Human DNA repair disorders in dermatology: A historical perspective, current concepts and new insight.
Moriwaki S
J Dermatol Sci; 2016 Feb; 81(2):77-84. PubMed ID: 26493104
[TBL] [Abstract][Full Text] [Related]
60. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
